Eli Lilly and Company – Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI)

Access Program Information

The Requesting Physician/Investigator contacts Lilly when, based on their medical opinion, a
patient meets the criteria for inclusion in the expanded access program.

Rare Disease: